These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
572 related items for PubMed ID: 7690863
21. Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system. Allen JC, Kim JH, Packer RJ. J Neurosurg; 1987 Jul; 67(1):65-70. PubMed ID: 2439668 [Abstract] [Full Text] [Related]
22. Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997. Haas RJ, Schmidt P, Göbel U, Harms D. Klin Padiatr; 1999 Jul; 211(4):300-4. PubMed ID: 10472566 [Abstract] [Full Text] [Related]
23. [Dysgerminomas. Clinical aspects, therapy and prognosis with reference to the cooperative therapy study MAIKEI 83/86 for non-testicular germ cell tumors of the Society of Pediatric Oncology]. Göbel U, Bamberg M, Calaminus G, Jürgens H, Pelzer V, Simon WE, Terruhn V, Wolf A, Mecke H, Harms D. Geburtshilfe Frauenheilkd; 1989 Aug; 49(8):737-42. PubMed ID: 2792708 [Abstract] [Full Text] [Related]
24. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96. Biskup W, Calaminus G, Schneider DT, Leuschner I, Göbel U. Klin Padiatr; 2006 Aug; 218(6):303-8. PubMed ID: 17080331 [Abstract] [Full Text] [Related]
25. [Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents--concept of the MAKEI 83 cooperative therapeutic study of the Society for Pediatric Oncology]. Göbel U, Haas RJ, Harms D, Janka G, Brämswig J, Jürgens H, Weissbach L, Faber P, Müller E. Klin Padiatr; 1983 Aug; 195(3):201-6. PubMed ID: 6192281 [Abstract] [Full Text] [Related]
27. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL]. Reiter A, Schrappe M, Yakisan E, Sauter S, Ebell W, Zimmermann M, Hartmann W, Kremens B, Kuhn N, Claviez A. Klin Padiatr; 1994 Aug; 206(4):242-52. PubMed ID: 7967420 [Abstract] [Full Text] [Related]
30. The malignant potential of teratomas in infancy and childhood: the MAKEI experiences in non-testicular teratoma and implications for a new protocol. Göbel U, Calaminus G, Schneider DT, Koch S, Teske C, Harms D. Klin Padiatr; 2006 Aug; 218(6):309-14. PubMed ID: 17080332 [Abstract] [Full Text] [Related]
31. Radiation therapy of intracranial germ cell tumors with radiosensitivity assessment. Nakagawa K, Aoki Y, Akanuma A, Sakata K, Karasawa K, Terahara A, Onogi Y, Hasezawa K, Muta N, Sasaki Y. Radiat Med; 1992 Aug; 10(2):55-61. PubMed ID: 1320768 [Abstract] [Full Text] [Related]
33. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group. J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987 [Abstract] [Full Text] [Related]
34. Malignant mediastinal germ cell tumors: an intergroup study. Billmire D, Vinocur C, Rescorla F, Colombani P, Cushing B, Hawkins E, London WB, Giller R, Lauer S. J Pediatr Surg; 2001 Jan 15; 36(1):18-24. PubMed ID: 11150432 [Abstract] [Full Text] [Related]
35. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors. Kim A, Ji L, Balmaceda C, Diez B, Kellie SJ, Dunkel IJ, Gardner SL, Sposto R, Finlay JL. Pediatr Blood Cancer; 2008 Dec 15; 51(6):768-73. PubMed ID: 18802946 [Abstract] [Full Text] [Related]
36. Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma. Report of five cases. Ushio Y, Kochi M, Kuratsu J, Itoyama Y, Marubayashi T. J Neurosurg; 1999 Jan 15; 90(1):133-7. PubMed ID: 10413166 [Abstract] [Full Text] [Related]
37. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T, Children's Cancer Group. J Clin Oncol; 2005 Oct 20; 23(30):7621-31. PubMed ID: 16234523 [Abstract] [Full Text] [Related]
38. Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Société Française d'Oncologie Pédiatrique. Bouffet E, Baranzelli MC, Patte C, Portas M, Edan C, Chastagner P, Mechinaud-Lacroix F, Kalifa C. Br J Cancer; 1999 Mar 20; 79(7-8):1199-204. PubMed ID: 10098759 [Abstract] [Full Text] [Related]
39. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma. Newlands ES. Semin Oncol; 1985 Mar 20; 12(1 Suppl 2):37-41. PubMed ID: 2579442 [Abstract] [Full Text] [Related]
40. [Results of the cooperative Malignant Testicular Tumors 82 Study of the German Society of Pediatric Oncology on the therapy of malignant germ cell tumors in childhood]. Haas RJ, Göbel U, Harms D, Schmidt P, Weissbach L. Klin Padiatr; 1988 Mar 20; 200(3):230-5. PubMed ID: 2463403 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]